V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007036 | 290005365 | 1.75 | 103.15 | Adjuvant (A) | 2017-01-23 | 2017-01-23 | FLUOROURACIL + MITOMYCIN | N | null | 290021803 | CAPECITABINE + OXALIPLATIN |
| 290007037 | 290005368 | 1.79 | 76 | Neo-adjuvant (N) | 2017-02-13 | 2017-02-13 | CETUXIMAB | 2 | 2 | 290021808 | CISPLATIN + FLUOROURACIL + RT |
| 290007038 | 290005368 | null | 56.2 | null | 2014-11-11 | 2014-11-11 | Trastuzumab Subcutaneous | N | null | 290021808 | CAPECITABINE |
| 290007039 | 290005369 | null | 92.3 | Palliative (P) | 2017-06-04 | 2017-06-04 | Irinotecan | null | Y | 290021819 | PEMBROLIZUMAB |
| 290007040 | 290005372 | 1.8 | 72.4 | Palliative (P) | 2018-01-03 | 2018-01-10 | Capecitabine + Streptozocin | null | N | 290021822 | CAPECITABINE + CARBOPLATIN |
| 290007041 | 290005372 | 1.75 | 56.5 | Palliative (P) | null | 2014-09-04 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290021822 | CARBOPLATIN + PACLITAXEL |
| 290007042 | 290005373 | 1.68 | 71.3 | Palliative (P) | 2016-11-26 | 2016-11-26 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 290021848 | OCTREOTIDE |
| 290007043 | 290005374 | null | 0 | Curative (C) | 2014-07-29 | 2014-07-30 | Capecitabine + Mitomycin | N | N | 290021849 | CISPLATIN + RT |
| 290007044 | 290005374 | 1.74 | 107 | Palliative (P) | 2016-01-09 | 2016-01-16 | CISPLATIN + RT | N | N | 290021849 | INTERAACT TRIAL |
| 290007045 | 290005375 | 1.66 | 70.7 | Adjuvant (A) | 2017-07-17 | 2017-07-30 | Cisplatin + Radiotherapy | 01 | N | 290021863 | CAPECITABINE + OXALIPLATIN |
| 290007046 | 290005376 | null | 130.6 | Palliative (P) | 2013-08-16 | 2013-08-29 | PACLITAXEL | 2 | N | 290021869 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290007047 | 290005376 | 0 | 55 | Palliative (P) | 2015-05-08 | 2015-06-02 | CARBOPLATIN + RT | N | N | 290021869 | DOCETAXEL |
| 290007048 | 290005377 | 0 | 59.8 | Disease modification (D) | 2016-12-28 | 2016-12-28 | Sunitinib | N | N | 290021877 | BCG |
| 290007049 | 290005378 | 0 | 96 | Palliative (P) | 2018-04-03 | 2018-04-12 | CAPECITABINE + CARBOPLATIN | 02 | N | 290021877 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 290007050 | 290005379 | 1.53 | 73 | Curative (C) | 2014-10-21 | 2014-11-02 | LANREOTIDE | N | N | 290021881 | CISPLATIN |
| 290007051 | 290005380 | 1.7 | null | Palliative (P) | 2018-08-04 | 2018-08-04 | Capecitabine | 02 | N | 290021885 | CISPLATIN + FLUOROURACIL + MITOMYCIN |
| 290007052 | 290005381 | null | 76 | Curative (C) | 2018-06-02 | 2018-07-12 | CETUXIMAB + RT | N | null | 290021885 | TRIAL |
| 290007053 | 290005386 | null | 60.05 | Palliative (P) | 2018-06-15 | 2018-06-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 290021890 | CETUXIMAB + OXALIPLATIN + MDG |
| 290007054 | 290005386 | 1.84 | 81.5 | Palliative (P) | 2018-08-18 | 2018-08-25 | Sunitinib | 2 | N | 290021890 | MCX |
| 290007055 | 290005386 | 1.6 | 48.2 | Adjuvant (A) | null | 2018-09-27 | Capecitabine 35days + RT | N | N | 290021890 | FEC |
| 290007056 | 290005387 | 1.76 | 90 | Palliative (P) | 2017-06-17 | 2017-07-21 | Trifluridine + Tipiracil | N | N | 290021900 | INTERAACT TRIAL |
| 290007057 | 290007281 | null | 74.3 | Palliative (P) | 2016-07-07 | 2016-07-19 | MITOMYCIN | 2 | N | 290021905 | LANREOTIDE |
| 290007058 | 290007281 | 1.65 | null | Palliative (P) | 2016-02-27 | 2016-08-21 | Cisplatin + Docetaxel +Fluorouracil | N | null | 290021905 | RALTITREXED |
| 290007059 | 290007283 | null | null | Not known (9) | null | 2017-01-26 | CAPECITABINE + MITOMYCIN + RT | null | N | 290021915 | FLUOROURACIL + MITOMYCIN |
| 290007060 | 290008029 | 1.68 | 49.5 | Palliative (P) | 2017-07-02 | 2017-07-03 | CETUXIMAB + RT | 02 | N | 290021918 | CARBOPLATIN + PACLITAXEL |
| 290007061 | 290005391 | null | 63.9 | null | null | 2017-09-24 | FLUOROURACIL + MITOMYCIN | N | null | 290021951 | FLUOROURACIL + MITOMYCIN |
| 290007062 | 290008030 | 1.82 | null | Palliative (P) | 2013-05-09 | 2013-05-09 | Capecitabine 35days + RT | null | N | 290021952 | EVEROLIMUS |
| 290007063 | 290008305 | 1.4 | 50 | Palliative (P) | 2015-01-28 | 2015-02-01 | Fluorouracil PVI + Mitomycin 42 day | 02 | N | 290021955 | CARBOPLATIN |
| 290007064 | 290005394 | 1.66 | 61.1 | Curative (C) | 2017-04-28 | 2017-04-28 | CompARE Trial | 2 | N | 290021966 | TRIAL |
| 290007065 | 290005394 | 1.53 | 56.4 | null | 2018-06-29 | 2018-07-14 | CETUXIMAB | N | N | 290021966 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290007067 | 290005395 | null | 67.25 | Palliative (P) | 2018-05-28 | 2018-06-02 | Capecitabine + Oxaliplatin 21day | N | N | 290021972 | CAPECITABINE + IRINOTECAN |
| 290007068 | 290005396 | 1.76 | null | Disease modification (D) | 2016-10-09 | 2016-10-23 | CETUXIMAB + RT | 02 | N | 290021981 | FLUOROURACIL + MITOMYCIN |
| 290007069 | 290005397 | 1.65 | null | Palliative (P) | 2016-09-16 | 2016-09-26 | CARBOPLATIN + PACLITAXEL | 02 | N | 290021986 | PACLITAXEL |
| 290007070 | 290005398 | 1.68 | 74.8 | Palliative (P) | 2014-11-22 | 2014-12-08 | Cisplatin + Radiotherapy | N | N | 290021987 | OCTREOTIDE |
| 290007071 | 290007287 | null | 86.3 | Palliative (P) | 2015-10-11 | 2015-10-17 | CHOP R - 21 days | 02 | N | 290021989 | ECX |
| 290007072 | 290005399 | null | 66.7 | null | 2015-09-23 | 2015-09-30 | Cetuximab 7 day (>Cycle 2) | N | N | 290021991 | CARBO + FLUOROURACIL |
| 290007073 | 290005399 | 1.63 | null | Palliative (P) | 2018-04-16 | 2018-04-21 | LANREOTIDE | 02 | N | 290021991 | CARBO + FLUOROURACIL |
| 290007074 | 290005400 | 1.65 | 74.4 | Curative (C) | 2017-07-27 | 2017-08-05 | Y-90 | N | null | 290021999 | CHOP R |
| 290007075 | 290005402 | 1.68 | 74.2 | Palliative (P) | 2015-12-16 | 2015-12-21 | LANREOTIDE | 02 | N | 290022005 | NOT MATCHED |
| 290007076 | 290005403 | 1.66 | null | null | 2016-02-07 | 2016-02-29 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 290022008 | IPILIMUMAB |
| 290007077 | 290005405 | 1.73 | 79 | Curative (C) | 2018-04-19 | 2018-04-27 | Carboplatin AUC 6 - 10 | 02 | N | 290022012 | CISPLATIN + RT |
| 290007078 | 290005405 | 1.57 | 48.1 | Curative (C) | 2018-09-10 | 2018-10-09 | OCTREOTIDE | N | N | 290022012 | CISPLATIN + FLUOROURACIL + RT |
| 290007079 | 290005407 | 1.73 | 43.9 | Palliative (P) | 2016-04-28 | 2016-06-19 | null | N | N | 290022019 | DOXORUBICIN + OLARATUMAB |
| 290007080 | 290007290 | 0 | null | Palliative (P) | 2014-03-31 | 2014-08-13 | LANREOTIDE | N | N | 290022022 | CAPECITABINE + MITOMYCIN + RT |
| 290007081 | 290005408 | 1.74 | null | Palliative (P) | 2013-11-18 | 2013-11-26 | GemCarbo Days 1+8 | N | N | 290022023 | MELPHALAN |
| 290007082 | 290005408 | 1.72 | 82 | Palliative (P) | 2018-04-16 | 2018-05-01 | CAPECITABINE + RT | N | N | 290022023 | OCTREOTIDE |
| 290007083 | 290005409 | null | null | Palliative (P) | 2016-06-05 | 2016-11-06 | Fluorouracil PVI + Mitomycin 21day | N | N | 290022034 | CAPECITABINE + OXALIPLATIN |
| 290007084 | 290005409 | 1.77 | 66.7 | Disease modification (D) | 2013-12-05 | 2013-12-15 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 290022034 | ABVD |
| 290007085 | 290005410 | 1.6 | 98 | Palliative (P) | 2017-11-23 | 2017-11-24 | CAPECITABINE + OXALIPLATIN | N | N | 290022047 | CAPECITABINE + IRINOTECAN |
| 290007086 | 290005411 | 1.6 | 76.8 | Palliative (P) | 2016-02-08 | 2016-02-10 | Cisplatin + Radiotherapy | N | N | 290022052 | CETUXIMAB |